Author name: Emily Wheeler

Emily Wheeler is Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Ms. Wheeler is responsible for working with member companies engaged in antimicrobial research, development, and commercialization, and leads BIO’s antimicrobial resistance (AMR) legislative and regulatory policy efforts. She is also the Director of the Working to Fight AMR public awareness campaign.

A close-up image of drug-resistant superbug Shigella provided by the CDC

We’re losing the fight against superbugs. The time to act is now.

BIO's View, Editors' Choice, Health, Latest News

Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR). […]

We’re losing the fight against superbugs. The time to act is now. Read More »

Author name: Emily Wheeler

We’re losing the fight against superbugs. The time to act is now.

Start typing and press enter to search